Menzies Scholarship to help Pelvic Organ Prolapse research and Assisted Reproductive Technology research
Congratulations to Ritesh Warty and Hope Newman on receiving MedTech Actuator's 2021 Menzies Scholarship. The scholarship valued at $10,000 and a $1000 stipend for each researcher will provide Ritesh and Hope with training in entrepreneurship and commercialisation that can assist with the translation of our technologies.
PhD candidate in the Department of Obstetrics and Gynaecology, Ritesh's research aims to develop and evaluate a novel device that can rehabilitate women who suffer from pelvic organ prolapse (POP). POP is a common gynaecological condition which can negatively impact the quality-of-life of women. It typically affects women above the age of 50 as well as women post-partum.
Ritesh said, "I was especially surprised by how common POP is and how, despite considerable limitations in existing management protocols, there has been little innovation in the area. This is truly a healthcare inequity for the women of our society. To help me in further developing this idea, I have formed a team of amazing clinicians and engineers. Together, hopefully we can produce a product that can have tangible benefits to these women and the healthcare system. I believe the training from this scholarship program can facilitate this".
Hope, also a PhD candidate in the Department of Obstetrics and Gynaecology is examining potential biomarkers of egg DNA repair capacity with aging, sperm DNA damage levels and live birth data to draw conclusions regarding egg DNA repair capacity and assisted reproductive technology outcomes, potentially using this information in a clinical setting to further advise patient treatment.
"I am incredibly excited to learn and grow with guidance from the mentors at the MedTech Actuator and to meet like-minded junior scientists. I believe that learning the steps of commercialization of medical devices and diagnostics will be a very beneficial addition to my research on reproductive aging", said Hope.